###begin article-title 0
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
Autoregulation of Th1-mediated inflammation by twist1
###end article-title 0
###begin p 1
###xml 33 49 33 49 <email xmlns:xlink="http://www.w3.org/1999/xlink">radbruch@drfz.de</email>
CORRESPONDENCE Andreas Radbruch: radbruch@drfz.de
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 230 236 222 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 320 326 312 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 517 523 505 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 650 656 638 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 963 969 951 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 985 991 973 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 866 874 <span type="species:ncbi:9606">patients</span>
The basic helix-loop-helix transcriptional repressor twist1, as an antagonist of nuclear factor kappaB (NF-kappaB)-dependent cytokine expression, is involved in the regulation of inflammation-induced immunopathology. We show that twist1 is expressed by activated T helper (Th) 1 effector memory (EM) cells. Induction of twist1 in Th cells depended on NF-kappaB, nuclear factor of activated T cells (NFAT), and interleukin (IL)-12 signaling via signal transducer and activator of transcription (STAT) 4. Expression of twist1 was transient after T cell receptor engagement, and increased upon repeated stimulation of Th1 cells. Imprinting for enhanced twist1 expression was characteristic of repeatedly restimulated EM Th cells, and thus of the pathogenic memory Th cells characteristic of chronic inflammation. Th lymphocytes from the inflamed joint or gut tissue of patients with rheumatic diseases, Crohn's disease or ulcerative colitis expressed high levels of twist1. Expression of twist1 in Th1 lymphocytes limited the expression of the cytokines interferon-gamma, IL-2, and tumor necrosis factor-alpha, and ameliorated Th1-mediated immunopathology in delayed-type hypersensitivity and antigen-induced arthritis.
###end p 3
###begin p 4
Abbreviations used: CD, Crohn's disease; ChIP, chromatin immunoprecipitation; CM, central memory; DTH, delayed-type hypersensitivity; EM, effector memory; shRNA, small hairpin RNA; UC, ulcerative colitis.
###end p 4
###begin p 5
U. Niesner and I. Albrecht contributed equally to this paper.
###end p 5
###begin p 6
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist2</italic>
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dermo1</italic>
###xml 160 183 160 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 374 380 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist2</italic>
###xml 411 417 411 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 422 428 422 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist2</italic>
###xml 554 560 554 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 565 571 565 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist2</italic>
###xml 675 676 671 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 678 679 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 160 183 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">Mice</span>
Twist1 and the closely related twist2 (also known as dermo1) genes encode basic helix-loop-helix transcription factors involved in the formation of mesoderm in Drosophila melanogaster (1), cranial neural tube and limb morphogenesis in mice (2), metastasis of tumor cells (3), control of apoptosis, and expression of cytokine genes in inflammation (4, 5). Mice deficient for twist2 or haploinsufficient for both twist1 and twist2 succumb to severe systemic inflammation, demonstrating the central role of Twist proteins in the regulation of inflammation. Twist1 and twist2 are expressed by fibroblasts and macrophages, and expression is promoted by TNF-alpha and type I IFNs (4, 5). The involvement of Twist expression by fibroblasts and macrophages in the control of inflammation is probable, but has not been investigated in detail so far.
###end p 6
###begin p 7
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 764 765 752 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 898 900 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 902 904 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 1107 1109 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 1111 1113 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 1244 1246 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 1343 1345 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 1451 1453 1423 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 1455 1457 1427 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 136 142 <span type="species:ncbi:10090">murine</span>
T helper 1 (Th1) lymphocytes are potent inducers of inflammation. This has been demonstrated by adoptive transfer of Th1 lymphocytes in murine models of Th1-associated inflammatory diseases such as diabetes (6), inflammatory bowel disease (7), and rheumatoid arthritis (8). In these models, the induction of inflammation in a particular tissue by Th1 lymphocytes is dependent on restimulation by the cognate antigen in that tissue. Induction of inflammation by Th1 cells is mediated by expression of the proinflammatory cytokines TNF-alpha and IFN-gamma, the latter being a hallmark of Th1 differentiation. IFN-gamma also induces expression of the chemokine receptor CXCR3 and its ligands CXCL9, -10, and -11, attracting Th1 cells specifically to inflamed tissue (9). Th cells with the capacity to recall IFN-gamma expression, i.e., Th1 memory cells, are detectable in chronically inflamed tissue (10, 11). The role of Th1 cells in the development and maintenance of chronic inflammation is less clear. Anti-IFN-gamma therapy has been shown to be beneficial in various Th1-associated inflammatory diseases (12, 13). However, a regulatory role for IFN-gamma has also been demonstrated, based on the induction of inducible nitric oxide synthase (14) and of IL-12 in antigen-presenting cells, in turn increasing the IL-10 synthesis of Th1 cells (15). Furthermore, IFN-gamma inhibits the differentiation of naive Th cells into proinflammatory Th17 cells (16, 17).
###end p 7
###begin p 8
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 117 123 117 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 252 254 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 297 303 293 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 337 343 333 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 686 692 674 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 940 946 928 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 502 510 <span type="species:ncbi:9606">patients</span>
###xml 586 594 <span type="species:ncbi:9606">patients</span>
###xml 804 810 <span type="species:ncbi:10090">murine</span>
In this study, we demonstrate specific autoregulation of Th1 cells by the transcription factor twist1. Expression of twist1 in Th cells is induced by IL-12/STAT4, NF-kappaB, and NFAT, and thus is specific for Th1 cells. Th1 effector memory (EM) cells (18) show increased transient reexpression of twist1 upon T cell receptor engagement. Twist1 reduces the functionality of Th1 cells by attenuating expression of IL-2, TNF-alpha, and IFN-gamma. Th cells isolated from chronically inflamed gut tissue of patients with ulcerative colitis (UC) or Crohn's disease (CD) and synovial fluid of patients with spondyloarthropathies or rheumatoid arthritis are imprinted to express high levels of twist1, which indicates a history of repeated restimulation and an involvement in the pathogenesis of the disease. In murine models of acute and chronic inflammation, i.e., delayed-type hypersensitivity (DTH) and antigen-induced arthritis, expression of twist1 by Th1 cells regulates Th1-mediated inflammation.
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
Twist1 is transiently expressed in repeatedly activated Th1 cells
###end title 10
###begin p 11
###xml 214 215 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 220 222 220 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 361 368 361 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink">327-339</sub>
###xml 706 712 706 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 728 734 728 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 116 122 <span type="species:ncbi:10090">murine</span>
To define transcriptional changes during Th1 memory cell differentiation, we compared the global gene expression of murine Th1 cells, which were activated with antigen once or repeatedly at 6-d intervals. Naive CD4+CD62Lhi T lymphocytes expressing the transgenic DO11.10 TCR specific for OVA were activated in vitro with splenic APCs and the cognate peptide OVA327-339 under conditions that induce functional differentiation into Th1 cells, i.e., addition of IL-12 and blocking antibodies specific for IL-4. The transcriptional profiles of once- and four-time-stimulated Th1 cells were compared using high-density DNA microarrays. Among the 17 genes differentially expressed by a factor of two or more was twist1. Expression of twist1 was up-regulated 38-fold in four-time- versus once-stimulated Th1 cells (Table S1, available at ).
###end p 11
###begin p 12
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 85 91 85 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 319 321 319 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 386 394 386 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 483 489 483 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 814 822 802 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 877 883 865 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 984 990 972 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1115 1123 1103 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 1140 1146 1128 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1283 1289 1271 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1340 1348 1328 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
Twist1 expression in Th1, but not Th2 or Th17, cells was confirmed by real-time PCR (Fig. 1). Twist1 mRNA expression in resting Th1 cells correlated with their age in vitro and the number of restimulations they had experienced. Expression was further enhanced 3 h after polyclonal stimulation either with PMA and the Ca2+ ionophore ionomycin, or with CD3- and CD28-specific antibodies (Fig. 1 A). When determined 3 h after restimulation with anti-CD3/-CD28 antibodies, expression of twist1 was close to the detection limit in naive Th cells. Expression increased approximately15-fold during the first Th1-polarizing stimulation, another 10-fold during the second stimulation, and another 3-fold during the third stimulation, reaching the maximum level after the fourth stimulation and remaining stable thereafter (Fig. 1 A). With PMA/ionomycin restimulation, maximum levels of twist1 mRNA were reached after two rounds of stimulation. In Th1 cells, upon anti-CD3/-CD28 restimulation, twist1 mRNA expression was up-regulated within the first hour, reaching maximum levels after 3 h, and decreasing again thereafter (Fig. 1 B). Expression of twist1 mRNA was also detectable in restimulated Th2 cells, but its level remained 30-fold lower than in Th1 cells. In Th17 cells, the level of twist1 mRNA expression was even lower than in Th2 cells (Fig. 1 C).
###end p 12
###begin p 13
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 0 63 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Twist1</italic> expression is induced in Th1, but not Th2 or Th17 cells.</bold>
###xml 67 68 67 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 73 75 73 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 340 346 340 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 661 667 661 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 810 816 810 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
Twist1 expression is induced in Th1, but not Th2 or Th17 cells. CD4+CD62Lhi OVA-specific T lymphocytes were stimulated in vitro under Th1 or Th2, or under Th17-polarizing conditions. Functional polarization of Th1, Th2, and Th17 cells, i.e., the cytokine expression profile, was confirmed by intracellular immunofluorescence (Fig. S1). (A) Twist1 mRNA in resting cells 6 d after the last stimulation (Th1; circles) or after 3 h of restimulation with anti-CD3/CD28 and IL-2 (Th1; squares) or PMA/ionomycin and IL-2 (Th1; triangles: Th2; diamonds) was determined by RT-PCR and normalized to hypoxanthine guanine phosphoribosyl transferase (HPRT). (B) Kinetics of twist1 mRNA expression in 6-d-old (open bars) and 24-d-old (shaded bars) Th1 cells, after stimulation with anti-CD3/CD28 and IL-2 or IL-2 alone. (C) Twist1 transcript levels in 6-d-old Th1, Th2, and Th17 cells after reactivation with PMA/ionomycin. (D) Twist1 protein expression in resting (-) and 5 h PMA/ionomycin-restimulated (+) 6- and 24-d-old Th1 and Th2 cells. Control: alpha-Tubulin immunoblot (bottom). (E) Kinetics of Twist1 protein expression in 24-d-old Th1 cells, before and at the indicated time intervals of stimulation with anti-CD3/CD28 and IL-2. Data are representative of two experiments. Fig. S1 is available at .
###end p 13
###begin p 14
###xml 220 228 220 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 267 273 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 409 417 409 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
Twist1 protein was detectable in 6-d-old restimulated Th1 cells. In 24-d-old Th1 cells, expression was enhanced. In resting Th1 cells and in reactivated or resting Th2 cells, Twist1 was not detectable by immunoblotting (Fig. 1 D). In agreement with the expression of twist1 mRNA, Twist1 protein expression peaked 3 h after reactivation, and then ceased, with levels still detectable 48 h after restimulation (Fig. 1 E), but not at 6 d after restimulation.
###end p 14
###begin p 15
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist2</italic>
Twist2 was not expressed in the Th1 and Th2 cells analyzed here, as determined by real-time PCR (unpublished data).
###end p 15
###begin title 16
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
Control of twist1 expression in Th1 lymphocytes
###end title 16
###begin p 17
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 213 219 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 260 268 260 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 316 322 312 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 359 367 355 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 448 450 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 500 506 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 518 527 514 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">of twist1</italic>
###xml 595 603 591 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 B</xref>
###xml 655 661 651 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
The specific expression of twist1 by activated Th1 cells suggests that Th1-polarizing or Th1-specific signals are required for the induction of twist1 expression in Th cells. Indeed, IL-12/STAT4 signaling induced twist1 expression in a dose-dependent fashion (Fig. 2 A). IFN-gamma and STAT1 signaling did not induce twist1 expression in the absence of IL-12 (Fig. 2 A). T-bet, a T box transcription factor sufficient to induce Th1 differentiation (19), is not required for induction of expression of twist1; induction of twist1 by IL-12 was comparable in T-bet-deficient and wild-type Th cells (Fig. 2 B). Also, ectopically expressed T-bet did not induce twist1 expression in the absence of IL-12 in activated Th cells (Fig. S2, available at ).
###end p 17
###begin p 18
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 0 81 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Twist1</italic> induction requires IL-12 signaling via STAT4, but not IFN-&#947; or T-bet. </bold>
###xml 90 92 86 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 408 414 396 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 518 524 506 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 673 675 659 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 693 696 679 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 926 932 906 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1000 1001 980 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1016 1019 996 999 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1275 1281 1249 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1515 1521 1489 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1610 1616 1584 1590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1802 1809 1774 1781 <sub xmlns:xlink="http://www.w3.org/1999/xlink">327-339</sub>
###xml 1934 1940 1906 1912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 1992 1998 1964 1970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 1040 1044 <span type="species:ncbi:10090">mice</span>
###xml 1210 1214 <span type="species:ncbi:10090">mice</span>
Twist1 induction requires IL-12 signaling via STAT4, but not IFN-gamma or T-bet. (A) CD62Lhi DO11.10 Th cells were stimulated for 5 d under Th1-polarizing conditions (5 ng/ml IL-12, anti-IL4), reduced IL-12 (1/25:200 pg/ml; 1/625:8 pg/ml, anti-IL4), in the absence of IL-12 (anti-IL-12, anti-IL4), in the presence of IFN-gamma (10 ng/ml IFN-gamma, anti-IL-12, anti-IL-4), or under Th2-polarizing conditions. Twist1 mRNA in Th cells activated for 3 h with PMA/ionomycin and IL-2 was quantified by RT-PCR. The amount of twist1 transcripts induced under Th1-polarizing conditions was set to 1. Data are presented as the mean +/- the SD of at least three experiments. (B) CD62Lhi Th cells of T-bet-/- mice and syngenic BALB/c mice were stimulated with anti-CD3/CD28 and BALB/c APCs under Th1 (IL-12 and IFN-gamma), or under Th2-polarizing conditions for 6 d. Data represent the mean +/- the SD of three experiments. The amount of twist1 transcripts induced in activated wt Th1 cells was set to 1. (C) CD4+ cells of STAT4-/- and syngenic BALB/c mice were stimulated with anti-CD3/CD28, and BALB/c APCs under Th1 (IL-12 and IFN-gamma) or under Th2-polarizing conditions for 5 d. Data represent the mean +/- SD (four mice each). (D) The binding of STAT4 to the proximal promoter of twist1 was analyzed by ChIP. 6-d-old Th1 cells were restimulated with PMA/ionomycin in the presence of 10 ng/ml IL-12 for 3 h or left unstimulated. The immunoprecipitated DNA was quantified by RT-PCR using primers specific for the proximal twist1 promoter. The precipitated DNA was normalized to the amount of input DNA. The amount of twist1 transcripts precipitated in the presence of IL-12 was set to 1. Data represent the mean +/- SD of three experiments. (E) Naive DO11.10 Th cells were stimulated for 5 d with APCs and OVA327-339 under Th1-polarizing conditions. Cells were restimulated under the same conditions (Th1), or in the presence of anti-IL-12. Twist1 transcripts were quantified on d 11. The amount of twist1 mRNA on d 5 was set to 1. Data represent mean +/- SD of three experiments.
###end p 18
###begin p 19
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 120 126 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 154 162 150 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 217 223 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 308 316 304 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 362 368 358 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 466 474 462 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 229 232 <span type="species:ncbi:9606">man</span>
###xml 237 242 <span type="species:ncbi:10090">mouse</span>
When CD4+ T lymphocytes of STAT4-deficient mice were stimulated in the presence of IL-12 and IFN-gamma, no induction of twist1 expression was detectable (Fig. 2 C). Phylogenetic comparison of the proximal promoter of twist1 from man and mouse revealed a conserved STAT binding site at position -117 to -137 (Fig. 3 A). STAT4 did bind to the proximal promoter of twist1 in activated Th1 cells in the presence of IL-12 as shown by chromatin immunoprecipitation (ChIP; Fig. 2 D).
###end p 19
###begin p 20
###xml 66 72 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 0 84 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Signaling through NFAT and NF-&#954;B is required for induction of <italic>twist1</italic> expression.</bold>
###xml 161 167 157 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 362 368 358 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 986 992 965 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1331 1337 1310 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 131 137 <span type="species:ncbi:10090">murine</span>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 197 203 <span type="species:ncbi:10090">murine</span>
Signaling through NFAT and NF-kappaB is required for induction of twist1 expression. (A) Comparison of the genomic sequence of the murine and the human proximal twist1 promoter (-150 to -100). The murine sequence is displayed with conserved bases in capital letters. Selected putative DNA-binding motifs are indicated. ISRE, IFN-stimulated response element. (B) Twist1 mRNA in 24-d-old Th1 cells restimulated for 3 h with PMA/ionomycin and IL-2 in the presence of serial dilutions of the NF-kappaB inhibitor pyrrolidine dithiocarbamate (PDTC; circles; starting concentration 50 muM), the NFAT inhibitor BTP1 (squares; starting concentration 100 nM), or the NF-kappaB and NFAT inhibitor cyclosporine A (CsA; triangles; starting concentration 30 nM). (C) 24-d-old Th1 cells were restimulated in the presence of IL-2 for 3 h with IL-2 alone (unstimulated) or 10 ng/ml TNF-alpha, PMA, or PMA/ionomycin. The binding of NFAT1 (D) and the NF-kappaB subunit p65 (E) to the proximal promoter of twist1 was analyzed by ChIP. 18-24-d-old Th1 and Th2 cells either in the resting state (-) or after restimulation with PMA/ionomycin and IL-2 for 1 h (+) were used. The immunoprecipitated DNA was quantified by RT-PCR using primers specific for the proximal promoter. The precipitated DNA was normalized to the amount of input DNA. The amount of twist1 transcripts precipitated in activated Th1 cells was set to 1. Data represent mean +/- SD of 3 experiments.
###end p 20
###begin p 21
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 286 292 286 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 356 364 356 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 407 413 407 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 530 536 526 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 588 594 584 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
IL-12/STAT4 is required for the initial induction of twist1 expression and apparently imprints Th1 cells for reexpression of twist1 upon reactivation by antigen only. Upon restimulation of Th1 cells, cells cultured in the absence of IL-12 showed a 12-fold increase in the expression of twist1, as compared with a 16-fold increase in the presence of IL-12 (Fig. 2 E). IL-4/STAT6 signaling could not suppress twist1 expression in residual IFN-gamma-expressing cells of Th2 cultures (Fig. S3, available at ), but also did not induce twist1 expression in activated Th2 cells, as described in Fig. 1.
###end p 21
###begin p 22
###xml 8 14 8 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 131 137 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 268 274 264 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 328 336 324 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 392 394 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 475 477 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 526 528 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 582 588 574 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 595 603 587 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 673 679 661 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 793 795 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 826 832 806 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 912 920 892 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 C</xref>
Because twist1 is expressed transiently upon activation of Th1 cells, we investigated whether signals from the TCR are involved in twist1 expression control. Phylogenetically conserved binding sites for the TCR signal transducers NF-kappaB and NFAT are located in the twist1 promoter at positions -104 to -116 and -129 to -140 (Fig. 3 A). The NF-kappaB inhibitor pyrrolidine dithiocarbamate (20), the NFAT-specific inhibitory 3,5-bistrifluoromethyl pyrazole derivative BTP1 (21), and the calcineurin-inhibitor cyclosporine A (22) all blocked the PMA/ionomycin-induced expression of twist1 mRNA (Fig. 3 B), showing that both NFAT and NF-kappaB are required for induction of twist1 expression in Th1 cells. Accordingly, stimulation with either TNF-alpha or PMA alone, both activating NF-kappaB (20) but not NFAT, did not induce twist1 expression, whereas PMA in combination with the NFAT-activating ionomycin did (Fig. 3 C).
###end p 22
###begin p 23
###xml 95 101 91 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 182 193 178 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, D&#8211;E</xref>
###xml 269 275 261 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 399 405 387 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 449 455 437 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 626 632 610 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
Using ChIP, the specific binding of NFAT1 and the transactivating NF-kappaB subunit p65 to the twist1 promoter of repeatedly stimulated Th1 cells was evident 1 h after reactivation (Fig. 3, D-E). In Th2 cells, no activation-induced binding of NFAT1 or NF-kappaB to the twist1 promoter was detectable, emphasizing that NFAT1 and NF-kappaB are required, but not sufficient, to induce transcription of twist1 in Th cells. For the initial expression of twist1 in Th1 cells, and its imprinting for reexpression in further restimulations, the concerted action of activated STAT4, NFAT1, and NF-kappaB is required. Imprinting of the twist1 gene for reexpression in Th1 cells is reflected by increased acetylation of histone H3 and trimethylated histone H3 at lysine 4, in both resting and reactivated Th1 cells, as compared with Th2 cells (Fig. S4, available at ).
###end p 23
###begin title 24
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
Th cell-specific twist1 expression in vivo
###end title 24
###begin p 25
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 112 118 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 168 170 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 184 185 184 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 190 192 190 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 342 348 342 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 350 358 350 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 367 368 367 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 373 375 373 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 445 452 445 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MRL/lpr</italic>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 463 469 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 538 539 538 539 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 544 546 544 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 577 585 577 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 588 594 588 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 647 648 647 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 652 653 652 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 671 674 671 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 675 679 <span type="species:ncbi:10090">mice</span>
The exclusive expression of twist1 in Th1 EM cells generated in vitro is reflected by the expression pattern of twist1 in Th cells isolated ex vivo. Activated CD4+CD62Lhi naive and CD4+CD62Llo memory cells isolated from the spleen and lymph nodes of healthy DO11.10 mice, kept under specific pathogen-free conditions, expressed low levels of twist1 (Fig. 4 A). In CD4+CD62Llo memory Th cells from lymph nodes of 4-6-mo-old nephritic lupus-prone MRL/lpr mice (23) twist1 mRNA was up-regulated by approximately twofold, as compared with CD4+CD62Llo Th cells from DO11.10 spleen (Fig. 4 A). Twist1 expression was enhanced by five- to eightfold in CD3+B220+ T cells from MRL/lpr mice, which represent chronically activated T lymphocytes (24, 25).
###end p 25
###begin p 26
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ex vivo isolated memory Th cells express <italic>twist1</italic>.</bold>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 415 416 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 421 423 421 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 437 440 437 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpr</italic>
###xml 473 474 473 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 502 508 502 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 573 579 573 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 631 632 631 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 635 636 635 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 753 754 753 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 760 761 760 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 765 766 765 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 776 777 776 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 783 784 783 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 788 789 788 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 799 800 799 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 806 807 806 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 811 812 811 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 882 888 882 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 907 908 907 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 911 912 911 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 978 979 978 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 982 983 982 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1337 1343 1337 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 528 533 <span type="species:ncbi:9606">human</span>
###xml 933 940 <span type="species:ncbi:9606">patient</span>
###xml 1100 1108 <span type="species:ncbi:9606">patients</span>
###xml 1257 1265 <span type="species:ncbi:9606">patients</span>
###xml 1323 1330 <span type="species:ncbi:9606">patient</span>
###xml 1378 1386 <span type="species:ncbi:9606">patients</span>
Ex vivo isolated memory Th cells express twist1. Cells were sorted by flow cytometry and restimulated for 3 h with PMA/ionomycin (A-C). (A) Cells were isolated from the spleen and lymph nodes of 8-12-wk-old DO11.10 mice (squares, each representing a pool of 15 individual mice) and the pooled inguinal and mesenteric lymph nodes of 4-6-mo-old nephritic MRL/lpr mice (circles, 1-2 mice each). Of note: 90% of the CD4+CD62Lhi cells in MRL/lpr mice represented activated (CD44+) cells (not depicted). (B) Twist1 mRNA in peripheral human Th lymphocytes. The mean expression of twist1 mRNA normalized to ubiquitin ligase H5 in total CD3+CD4+ cells was set to 1. Subpopulations were defined according to expression of the following surface markers: naive (CD4+CD45RA+CCR7+), CM (CD4+CD45RA-CCR7+), EM (CD4+CD45RA-CCR7-) with each data point representing one individual healthy donor. (C) Twist1 transcripts in CD3+CD4+ cells purified from patient material: blood (total peripheral CD3+CD4+ cells from healthy donors, see B), colon (noninflamed colon tissue), UC, and CD (endoscopic biopsies from UC and CD patients, respectively), RA, ReA, PsA, and AS (synovial fluid from rheumatoid arthritis, reactive arthritis, psoriatic arthritis, and ankylosing spondylitis patients, respectively) with each dot representing one individual patient. Mean twist1 mRNA expression is displayed from patients who were repeatedly sampled.
###end p 26
###begin p 27
###xml 64 78 64 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1. Twist1</italic>
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 247 248 247 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 252 253 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 291 292 291 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 296 297 296 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 329 335 329 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 443 449 443 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 593 601 593 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 14 20 <span type="species:ncbi:10090">murine</span>
###xml 37 42 <span type="species:ncbi:9606">human</span>
In analogy to murine Th lymphocytes, human Th cells can express twist1. Twist1 expression was enhanced by threefold in EM (i.e., CD45RA-CCR7-) Th cells, and eightfold in "terminally" differentiated CD27- EM Th cells (26, 27), whereas naive (CD45RA+CCR7+) and central memory (CM; i.e., CD45RA-CCR7+) Th lymphocytes expressed less twist1 than unseparated Th cells. Activated Th1 EM cells, characterized by the expression of CCR5 (28), expressed twist1, whereas Th2 EM cells characterized by expression of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTh2) (29) did not (Fig. 4 B).
###end p 27
###begin p 28
###xml 109 115 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 154 160 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 251 252 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 255 256 255 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 497 505 497 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 C</xref>
###xml 536 542 536 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 752 753 752 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 779 785 779 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 801 802 801 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 805 806 805 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 858 864 858 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
###xml 318 326 <span type="species:ncbi:9606">patients</span>
###xml 463 471 <span type="species:ncbi:9606">patients</span>
###xml 581 589 <span type="species:ncbi:9606">patients</span>
Th cells isolated from inflamed tissue of patients with chronic inflammatory diseases are imprinted for high twist1 expression. Although highly variable, twist1 transcripts were increased by up to 400-fold, as compared with peripheral Th cells, in CD3+CD4+ cells isolated from the synovial fluid of inflamed joints of patients with rheumatoid arthritis or spondyloarthropathies, and in Th cells isolated from mucosal endoscopic biopsies and surgical specimens of patients suffering from CD or UC (Fig. 4 C and Table S2, available at ). Twist1 mRNA expression in repeatedly sampled patients with persistent inflammation of colon or synovia remained in the same range over up to 18 mo (Table S2). Among T cells isolated from the inflamed tissue, only CD4+ Th cells showed enhanced twist1 expression. CD3+CD4- cells, i.e., cytotoxic (Tc) lymphocytes, expressed twist1 transcript levels lower than the reference value of total peripheral Th cells (unpublished data).
###end p 28
###begin title 29
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
Functional modulation of Th1 cells by twist1
###end title 29
###begin p 30
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 146 152 146 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 219 225 219 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 383 389 383 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 425 431 425 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 104 110 <span type="species:ncbi:10090">murine</span>
We analyzed the impact of twist1 on the function of Th1 EM cells by ectopic overexpression of twist1 in murine DO11.10 Th cells. A global view of twist1-induced modulation of gene expression in Th1 cells is provided in Fig. 5. Of the 14,000 genes analyzed for transcription, 58 were differentially expressed by a factor of 1.5 or more when comparing activated Th1 cells that express twist1 ectopically and those that do not (Fig. 5). These genes fall into 4 groups, with respect to their presumptive function: 17 genes are involved in cell activation and apoptosis, 11 genes are involved in cell adhesion and motility, 13 genes relate to the chemokine/cytokine repertoire of Th1 cells, and 17 genes are of metabolic or undefined relevance.
###end p 30
###begin p 31
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genes differentially expressed upon ectopic <italic>twist1</italic> overexpression.</bold>
###xml 141 148 141 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">327-339</sub>
###xml 256 263 256 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1-</italic>
###xml 354 357 354 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gfp</italic>
Genes differentially expressed upon ectopic twist1 overexpression. Splenic DO11.10 cells were activated in vitro with the cognate peptide OVA327-339 in the presence of 1 ng/ml IL-12 and 1 ng/ml IL-2. On d 2, cells were infected with control retrovirus, or twist1-encoding virus. On d 5, cells were sorted according to expression of the viral marker gene gfp. Cells were restimulated for 4 h with PMA/ionomycin. The transcriptional profiles of duplicates of cultures were compared.
###end p 31
###begin p 32
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 116 131 116 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">il-2, ifn-&#947;</italic>
###xml 137 146 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tnf-&#945;</italic>
###xml 173 179 165 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 377 383 369 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 590 596 582 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
Of relevance for the effector function of Th1 EM cells, twist1 attenuated expression of the effector cytokine genes il-2, ifn-gamma, and tnf-alpha by a factor of up to 1.6 (Fig. 5 and Table S3, available at ). The moderate reduction of mRNA levels of effector cytokines had a drastic effect on protein expression regardless of the direction of Th cell differentiation. Ectopic twist1 expression reduced the frequencies of cytokine-expressing reactivated Th1 or Th2, or of Th cells that had been stimulated without addition of polarizing cytokines to the culture, to 40-50% of the controls (Fig. 6 and Fig. S5).
###end p 32
###begin p 33
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Twist1</italic> suppresses the expression of effector cytokines.</bold>
###xml 221 227 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 418 424 418 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 550 553 550 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gfp</italic>
###xml 625 626 625 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 629 630 629 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 670 671 670 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 782 788 782 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
Twist1 suppresses the expression of effector cytokines. DO11.10 Th cells were stimulated for 5 d under Th1- or Th2-polarizing conditions or without addition of cytokines. On d 2, cells were infected with control virus or twist1-encoding virus. The cells were restimulated on d 6 and stained for intracellular cytokine expression. (A) Representative histograms of cytokine expression in Th cells ectopically expressing twist1 (black line) and control cells (gray filled). The cells displayed were gated for expression of CD4 and the viral marker gene gfp. (B) Frequencies of cytokine-expressing cells among infected, i.e., GFP+CD4+ T cells relative to the noninfected CD4+ cells. Cells had been stimulated without addition of cytokines and infected with control virus (open bars) or twist1-encoding virus (filled bars). Data represent the mean +/- SD of four independent experiments.
###end p 33
###begin p 34
###xml 69 75 69 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 157 158 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 325 326 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 356 362 352 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 546 554 534 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 A</xref>
###xml 613 635 601 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">inhibitor of NF-&#954;B</italic>
###xml 637 651 621 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I-&#954;B&#945;M</italic>
###xml 861 869 829 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7 B</xref>
###xml 897 903 865 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1115 1117 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 1119 1121 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 1143 1149 1103 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1184 1190 1144 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1240 1246 1200 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1</xref>
The molecular basis of the regulation of cytokine gene expression by twist1 could be either direct inhibition of NF-kappaB, as has been shown for COS cells (4), or binding of Twist1 to E-boxes of regulatory elements of the cytokine genes, blocking activating transcription factors, as has been shown for primary macrophages (5). Here, we show that ectopic twist1 expression in activated Th cells cannot inhibit activation-induced transcription of an NF-kappaB-reporter construct lacking E-boxes, i.e., Twist1 does not inhibit NF-kappaB directly (Fig. 7 A), in contrast to the constitutively active mutant form of inhibitor of NF-kappaB (I-kappaBalphaM), in an experimental situation where both Twist1 and I-kappaBalphaM are expressed at similar levels (Fig. S6, available at ), and both attenuate the expression of endogenous cytokine genes to the same degree (Fig. 7 B). This result implies that twist1 regulates gene expression of Th1 cells by binding to E-boxes of specific target genes, and not the entirety of NF-kappaB-regulated genes. NF-kappaB signaling for the generation and survival of Th1 memory cells (30, 31) is not inhibited by twist1, as is also evident from the high twist1 expression of repeatedly restimulated Th1 cells (Fig. 1).
###end p 34
###begin p 35
###xml 0 23 0 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inhibition of NF-&#954;B</bold>
###xml 46 52 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 24 74 20 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">mediated signaling by <italic>twist1</italic> is promoter-specific.</bold>
###xml 116 123 112 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink">327-339</sub>
###xml 198 205 194 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1,</italic>
###xml 310 328 298 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Renilla luciferase</italic>
###xml 336 354 324 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">firefly luciferase</italic>
###xml 545 548 525 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gfp</italic>
###xml 791 792 769 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 795 796 773 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Inhibition of NF-kappaB-mediated signaling by twist1 is promoter-specific. DO11.10 Th cells were stimulated with OVA327-339, APCs, and 1 ng/ml IL-12. On d 2, cells were infected with control virus, twist1, or I-kappaBalphaM-encoding virus. On d 3, cells were nucleoporated with a mixture of a plasmid encoding Renilla luciferase, and a firefly luciferase reporter construct, driven by a NF-kappaB-responsive promoter (4xkappaB-luc). (A) Cells were restimulated with PMA/ionomycin for 6 h, sorted according to expression of the viral marker gene gfp, and luciferase signals were quantified in duplicates (mean +/- SD). (B) The very same Th1 cultures were restimulated on d 5 and stained for intracellular cytokine expression. Frequencies of cytokine-expressing cells among infected, i.e., GFP+CD4+ T cells, are displayed. Data are representative of two experiments.
###end p 35
###begin title 36
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
Twist1 regulates Th1-mediated inflammation
###end title 36
###begin p 37
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 205 211 205 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 303 310 303 310 <sub xmlns:xlink="http://www.w3.org/1999/xlink">323-339</sub>
###xml 432 438 432 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 576 584 576 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 A</xref>
###xml 701 703 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 742 748 738 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 897 905 889 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 B</xref>
###xml 1023 1029 1015 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1094 1102 1086 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig8" ref-type="fig">Fig. 8 C</xref>
###xml 1137 1144 1129 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1-</italic>
###xml 5 11 <span type="species:ncbi:10090">murine</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
In a murine transfer model of OVA-specific DTH, the effect of twist1 expression on the inflammation induced by transferred Th1 cells was analyzed. OVA-specific 6-d-old Th1 cells ectopically overexpressing twist1 and control Th1 cells were transferred intravenously into naive BALB/c mice. After 1 d, OVA323-339 emulsified in IFA was injected into one footpad and the swelling of this footpad was monitored. Th1 cells overexpressing twist1 showed a significantly (P < 0.05) reduced induction of footpad swelling, starting from day 4 to 7, when compared with control Th1 cells (Fig. 8 A). For DTH mediated by Th1 cells the proinflammatory role of Th1-derived cytokines such as IFN-gamma has been shown (32). Transferred Th cells overexpressing twist1, when reisolated from the draining lymph nodes of the host, expressed fourfold reduced levels of IFN-gamma mRNA as compared with the control cells (Fig. 8 B). Homing of transferred Th1 cell populations to the inflamed tissue and the draining lymph nodes was not affected by twist1 overexpression, as shown by the transfer of radiolabeled cells (Fig. 8 C). The accumulation of ectopically twist1-expressing Th1 cells in the draining lymph nodes and the inflamed foot pads, as well as in other organs (Fig. S7, available at ), was comparable to that of transferred control Th1 cells.
###end p 37
###begin p 38
###xml 8 14 8 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ectopic <italic>twist1</italic> overexpression controls DTH.</bold>
###xml 180 186 180 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 318 325 318 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink">323-339</sub>
###xml 422 423 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 601 602 591 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 786 787 776 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1000 1001 984 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
Ectopic twist1 overexpression controls DTH. (A) Naive DO11.10 Th cells were stimulated under Th1-polarizing conditions. On d 2, cells were infected with control virus (circles) or twist1-encoding virus (squares). On d 6, infected GFP+ cells were injected i.v. into BALB/c mice. The DTH response was induced by s.c. OVA323-339/IFA injection into the left footpad (filled symbols), and Delta footpad thickness (mean +/- SD; n = 4, Mann-Whitney test, nonparametric) was determined thereafter. Injection of PBS/IFA served as control (open symbols). (B) Ex vivo IFN-gamma mRNA expression in transferred GFP+ Th1 cells 24 h after DTH induction isolated from the draining popliteal lymph node (left foot). (C) To monitor the migratory capacity of the transferred cell populations, infected GFP+ Th cells were radiolabeled and injected i.v. into BALB/c mice 1 d after induction of the DTH response. 24 h later radioactivity recovered from indicated tissues was determined using a gamma-counter (mean +/- SD; n = 4).
###end p 38
###begin p 39
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 138 146 138 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 A</xref>
###xml 220 226 220 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 395 401 395 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 450 456 450 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 523 529 523 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 597 605 585 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 B</xref>
###xml 926 932 914 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 1051 1062 1039 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9, C&#8211;E</xref>
###xml 1074 1080 1062 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1198 1206 1186 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig9" ref-type="fig">Fig. 9 F</xref>
###xml 1372 1379 1360 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10</xref>
###xml 1601 1608 1589 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10</xref>
###xml 1648 1649 1636 1637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1725 1726 1713 1714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1771 1777 1759 1765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 2022 2028 2002 2008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 2046 2053 2026 2033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10</xref>
###xml 2145 2151 2125 2131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 2181 2182 2161 2162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2226 2233 2206 2213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig10" ref-type="fig">Fig. 10</xref>
###xml 77 83 <span type="species:ncbi:10090">murine</span>
###xml 272 278 <span type="species:ncbi:10090">Murine</span>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
###xml 2130 2134 <span type="species:ncbi:10090">mice</span>
Autoregulation of Th1-mediated inflammation by twist1 was also analyzed in a murine adoptive transfer model of antigen-induced arthritis (Fig. 9 A). In this model, we used the complementary genetic approach to knockdown twist1 expression in Th1 cells by RNA interference. Murine DO11.10 Th1 cells generated in vitro were infected with a retrovirus encoding a small hairpin RNA (shRNA) targeting twist1 (3) or a corresponding scrambled control shRNA. Twist1-specific shRNA reduced the level of activation-induced endogenous twist1 transcripts in Th1 cells to approximately30% of the control value (Fig. 9 B). Two-time restimulated Th1 cells expressing those shRNAs were intravenously injected into SCID mice. 1 d after cell transfer, arthritis was induced by injection of cationized OVA into the knee joint, and histological analysis was performed 3 wk after induction of arthritis, i.e., in the chronic phase of inflammation. Twist1 knockdown and control Th1 cells equally homed to and persisted in the spleen and mesenteric and draining lymph nodes (Fig. 9, C-E). However, twist1 knockdown in Th1 cells resulted in a significantly higher histological score of inflammation and tissue destruction (Fig. 9 F and Table S4, available at ). In particular, infiltration of granulocytes and mononuclear cells into the inflamed tissue of the knee joint was drastically enhanced (Fig. 10 and Fig. S8), as were characteristics of chronic inflammation, i.e., prominent hyperplasia of the lining cells, pannus formation, increased vascularization, and hyperplasia of synovial fibroblasts in the sublining layer (Fig. 10 and Fig. S8). Increased numbers of Gr-1+ granulocytes at the surface of the synovium and focal accumulation of F4/80+ macrophages were observed after transfer of twist1 knockdown Th1 cells as compared with control Th1 cells (Fig. S8). Anti-TNF-alpha staining of joint sections revealed stronger TNF-alpha expression, especially in the lining cells and the sublining layer after transfer of Th1 cells expressing a twist1-targeting shRNA (Fig. 10). Presumably as an additional consequence of the higher inflammation in the mice receiving twist1 knockdown Th1 cells, more CD3+ T cells were found in the inflamed joints (Fig. 10).
###end p 39
###begin p 40
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Twist1</italic> knockdown increases inflammatory response in murine arthritis.</bold>
###xml 99 105 99 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 138 144 138 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 259 260 259 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 414 420 414 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 52 58 <span type="species:ncbi:10090">murine</span>
###xml 491 497 <span type="species:ncbi:10090">murine</span>
Twist1 knockdown increases inflammatory response in murine arthritis. (A) Experimental scheme. (B) Twist1 mRNA in 18-d-old Th1 expressing twist1-targeting shRNA or control shRNA restimulated with PMA/ionomycin. (C-E) Cell numbers of adoptively transferred GFP+ Th cells in spleen, mesenteric lymph nodes, and draining lymph nodes were analyzed on d 21 using FlowCount Beads. (F) Transfer of Th1 cells expressing a twist1-targeting shRNA leads to a significantly higher histological score in murine arthritis compared with control Th1 cells (d 21). Data are representative of two experiments.
###end p 40
###begin p 41
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Twist1</italic> knockdown leads to pronounced signs of chronic inflammation in murine arthritis.</bold>
###xml 298 299 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 560 566 553 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 70 76 <span type="species:ncbi:10090">murine</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
Twist1 knockdown leads to pronounced signs of chronic inflammation in murine arthritis. Representative hematoxylin/eosin staining of knee joint sections (d 21) showing hyperplasia of the lining cells and the subintimal layer with pannus formation (bar, 200 mum), more pronounced infiltration of CD3+ T cells (magnification of boxed areas in top row; bar, 100 mum) and stronger expression of TNF-alpha (red) especially of the enlarged lining and sublining layer (magnification of boxed areas in second row; bar, 50 mum) after transfer of Th1 cells expressing a twist1-targeting shRNA as compared with the control group. Data are representative of five mice each.
###end p 41
###begin title 42
DISCUSSION
###end title 42
###begin p 43
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist</italic>
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 109 115 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist2</italic>
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 237 243 237 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 383 389 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 497 503 493 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
Control of inflammation critically depends on the twist genes. Genetic haploinsufficiency of both twist1 and twist2 results in fatal systemic inflammatory immunopathology in mice, which die before day 14 (4). In this study, we show that twist1 is expressed in Th1 EM cells. Its expression is induced by IL-12 via STAT4 and TCR signaling, activating NFAT and NF-kappaB. Expression of twist1 follows TCR stimulation transiently and increases upon repeated stimulation. Thus, imprinting for enhanced twist1 expression is a hallmark of repeatedly restimulated Th1 memory cells.
###end p 43
###begin p 44
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 178 184 170 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 225 231 217 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 368 374 356 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 457 463 445 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 616 622 604 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 738 744 723 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 837 843 818 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1174 1180 1155 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1257 1263 1238 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1313 1319 1294 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1460 1461 1433 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 1527 1533 1500 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1535 1536 1508 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 1561 1566 1534 1539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist</italic>
###xml 1580 1586 1553 1559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1591 1597 1564 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist2</italic>
###xml 1647 1654 1620 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1.</italic>
###xml 1674 1680 1647 1653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1837 1843 1806 1812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1953 1958 1922 1927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist</italic>
###xml 2067 2068 2032 2033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 2070 2071 2035 2036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 2161 2166 2126 2131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist</italic>
###xml 537 543 <span type="species:ncbi:10090">murine</span>
The proximal promoter of twist1 contains phylogenetically conserved binding sites for NFAT, NF-kappaB, and STAT proteins. Both NFAT and NF-kappaB have to bind to the promoter of twist1 in Th cells to induce expression, i.e., twist1 is expressed only by activated Th cells. In the initial activation of naive Th cells, NFAT and NF-kappaB cannot induce transcription of twist1 on their own, but require concerted binding of activated STAT4 to the promoter of twist1. Of all costimulatory signals involved in the lineage differentiation of murine Th1, Th2, or Th17 cells, only IL-12 was able to induce transcription of twist1. Neither IL-4, in Th2 polarization, nor IL-6, TGF-beta, and IL-23 in Th17 polarization, could induce expression of twist1. Of the Th1-polarizing signals, IL-12/STAT4, but not IFN-gamma/STAT1, is required to induce twist1 expression. T-bet is not involved. STAT4 is required only in the original stimulation, to imprint the gene for reexpression. This imprinting is evident from the increased reexpression upon stimulation with TCR signals alone, in the absence of IL-12, and it is reflected in the acetylation and trimethylation of H3 histones at the twist1 promoter region, as is shown here. The requirement of NFAT for induction of twist1 expression in Th1 cells distinguishes control of twist1 expression in Th cells from its control in fibroblasts, where TNF-alpha-induced activation of NF-kappaB is sufficient to induce expression (4). In activated macrophages, type I IFNs induce the expression of twist1 (5), and they express both twist genes, i.e., twist1 and twist2, whereas activated Th1 cells exclusively express twist1. In Th lymphocytes, twist1 expression is not induced by type I IFNs. Addition of IFN-alpha during the primary activation of Th cells in the absence of IL-12 did not suffice to induce twist1 expression (Fig. S9, available at ). These findings provide evidence that expression of the antiinflammatory twist genes is controlled by type I IFNs and TNF-alpha in fibroblasts and macrophages in innate immune responses (4, 5), and is controlled by antigen and IL-12 in Th cells in adaptive immune responses; i.e., twist expression is induced by those cytokines controlling the induction of inflammatory immune responses.
###end p 44
###begin p 45
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 269 275 269 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 457 463 457 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 534 535 534 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 540 542 540 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 652 658 652 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 673 674 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 678 679 678 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 712 719 712 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MRL/lpr</italic>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 782 788 782 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1153 1159 1141 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1170 1176 1158 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1280 1281 1268 1269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1295 1301 1283 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 1332 1333 1320 1321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1400 1401 1388 1389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1405 1406 1393 1394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1417 1419 1405 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 1421 1423 1409 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 1436 1437 1424 1425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1448 1454 1436 1442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1481 1482 1469 1470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1539 1541 1527 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 1548 1549 1536 1537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1553 1554 1541 1542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1605 1607 1593 1595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 1660 1666 1648 1654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1747 1753 1735 1741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1777 1778 1765 1766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 1782 1783 1770 1771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1872 1878 1860 1866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1974 1980 1962 1968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 2010 2011 1998 1999 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2014 2015 2002 2003 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2170 2176 2158 2164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 2339 2345 2327 2333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 180 186 <span type="species:ncbi:10090">murine</span>
###xml 524 530 <span type="species:ncbi:10090">murine</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 720 724 <span type="species:ncbi:10090">mice</span>
###xml 1208 1213 <span type="species:ncbi:9606">human</span>
###xml 1248 1253 <span type="species:ncbi:9606">human</span>
###xml 1855 1860 <span type="species:ncbi:9606">human</span>
###xml 2058 2066 <span type="species:ncbi:9606">patients</span>
###xml 2145 2153 <span type="species:ncbi:9606">patients</span>
###xml 2393 2401 <span type="species:ncbi:9606">patients</span>
In this study, we have identified twist1 as a gene that is differentially expressed by Th1 cells versus Th2 cells, comparing the transcriptomes of once and repeatedly restimulated murine Th1 and Th2 cells generated in vitro from bona fide naive Th cells. Expression of twist1 increases upon repeated restimulation in vitro in Th1 cells, whereas it is not induced even in repeatedly restimulated Th2 or Th17 cells. Accordingly, in Th cells isolated ex vivo, twist1 expression is restricted to a subset of memory cells. Among murine CD4+CD62Llo memory-phenotype Th cells that were isolated from spleen or lymph nodes of naive DO11.10 mice, expression of twist1 is low. In CD3+B220+ T cells isolated from nephritic MRL/lpr mice, which represent chronically activated T cells (24, 25), twist1 expression is up-regulated five- to eightfold compared with DO11.10 memory-phenotype Th cells. This is moderate when compared with the approximately20-fold up-regulation upon repeated restimulation of Th1 cells observed in vitro, and may reflect the heterogeneous composition of the cell populations analyzed. As expected from the phylogenetic conservation of the twist1 promoter, twist1 is also expressed by activated human Th cells. It is low in peripheral human naive Th cells and in CCR7+ CM Th cells. Twist1 expression is enhanced in CCR7- EM Th cells, in particular in the "terminally differentiated" CCR7-CD27- EM cells (26, 27). Among CCR7- EM cells, twist1 is expressed less by CRTh2+ Th cells, which have been shown to be mostly Th2 cells (29). CCR7-CCR5+ EM cells, which contain Th1 EM and Th17 EM cells (33) have up-regulated activation-induced expression of twist1, as we show here. Because at least Th17 cells generated in vitro do not express twist1, the expression in CCR7-CCR5+ Th EM cells is probably caused by Th1 EM cells. Thus, the phenotype of human peripheral twist1-expressing Th cells is that of repeatedly restimulated Th1 EM cells. Remarkably, expression of twist1 is highly up-regulated in CD3+CD4+ T cells isolated from inflamed tissues of patients with chronic inflammation of joints or gut. Repeated biopsies from individual patients show persistent twist1 mRNA levels over time, i.e., the persistence of chronically reactivated Th1 cells, despite state-of-the-art therapeutic treatment. Their imprinting for increased twist1 expression, maintained over time in individual patients, indicates a history of repeated restimulation and an endogenous regulation of proinflammatory effector functions under the control of NFAT and NF-kappaB.
###end p 45
###begin p 46
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 261 262 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 310 316 306 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 414 415 410 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 460 466 456 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 592 598 584 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 688 694 680 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1074 1080 1066 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1235 1241 1219 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1492 1498 1476 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 290 296 <span type="species:ncbi:10090">murine</span>
Twist1 itself is a transcriptional repressor binding to E-boxes in the regulatory regions of target genes (34). For COS cells, it has been shown that ectopically expressed twist1 can interact directly with the p65 subunit of NF-kappaB and inhibit its function (4). In contrast, for primary murine macrophages, twist1 has been shown to block transcription of target genes by binding to E-boxes within the promoter (5). In this study, we show that in Th1 cells, twist1 cannot block NF-kappaB-driven transcription of a reporter gene construct that lacks E-boxes in the promoter, suggesting that twist1 acts through binding to E-boxes, as in macrophages. In accordance, ectopically expressed twist1 only regulates the expression of a restricted set of 58 genes in 1-wk-old Th1 cells by a factor of at least 1.5. Expression of 29 genes is up-regulated, and that of another 29 genes down-regulated. Apart from several genes of unknown and metabolic function, these genes are involved in survival, effector function, and motility of the cells. With respect to cytokine expression, twist1 reduces activation-induced expression of TNF-alpha, IL-2, and IFN-gamma by Th1 memory cells by >50% at the protein level. Apart from cytokine expression, twist1 also decreases expression of proinflammatory chemokines and chemokine receptors, and attenuates cytokine receptor signaling by up-regulating SOCS-1 and -2, the IL-1 decoy receptor, and by down-regulating Jak2, the kinase involved in IL-12 signaling. Twist1 in Th1 cells thus acts as an endogenous regulator limiting the proinflammatory potential of Th1 cells in the continuous presence of antigen, i.e., repeated activation of NFAT and NF-kappaB.
###end p 46
###begin p 47
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 196 202 196 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 374 380 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 759 765 759 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 807 813 807 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 939 945 939 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1122 1123 1122 1123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1146 1147 1146 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1250 1256 1246 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 139 145 <span type="species:ncbi:10090">murine</span>
###xml 469 475 <span type="species:ncbi:10090">murine</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 914 918 <span type="species:ncbi:10090">mice</span>
The key role of twist1 expression by Th1 cells for the self-limitation of Th1-induced inflammation is evident from the present analysis of murine models of inflammation. Ectopic overexpression of twist1 in 6-d-old Th1 cells, which still had a low endogenous expression level, drastically reduced their pathogenic contribution to DTH. Conversely, shRNA-mediated knockdown of twist1 in Th1 cells significantly enhanced their potential to induce chronic inflammation in a murine model of antigen-induced arthritis. In this model, OVA-specific Th1 cells, when adoptively transferred into SCID mice and challenged by intraarticular OVA, induce a chronic inflammation of the joint. Adoptive transfer of Th1 cells versus Th1 cells with a shRNA-mediated knockdown of twist1 expression demonstrates the relevance of twist1 expression by Th1 cells for the control of immunopathology. When analyzed on day 21 after transfer, mice with a knockdown of twist1 expression in Th1 cells showed increased hyperplasia of the lining cells and synovial fibroblasts in the sublining layer, pannus formation, and vascularization. Numbers of Gr-1+ granulocytes and F4/80+ macrophages, as well as TNF-alpha expression of lining and sublining cells, were increased in the Th1 twist1 knockdown situation.
###end p 47
###begin p 48
###xml 21 27 21 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 217 223 217 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 586 592 586 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 598 604 598 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
Why is expression of twist1 up-regulated gradually? One explanation might be that a regulatory gene is not expressed in initial Th1 activations, to allow full initial reactivity of the Th1 cells. Accordingly, ectopic twist1 expression in Th1 cells right from the beginning impairs their function in acute inflammation of DTH. In repeated restimulations, reflecting a lack of clearance of the antigen and increased risk of immunopathology, regulation of Th1 may help to limit immunopathology, as we show in the chronic inflammation of the antigen-induced arthritis model by knockdown of twist1, but twist1-expressing Th1 cells are still capable of driving inflammation.
###end p 48
###begin p 49
###xml 73 79 73 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 168 174 168 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Twist1</italic>
###xml 236 237 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 257 258 257 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 262 263 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 310 316 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 455 456 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 934 940 934 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 992 998 992 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 474 482 <span type="species:ncbi:9606">patients</span>
Apart from its role in limiting immunopathology in chronic inflammation, twist1 and the genes controlled by it could be regarded as biomarkers for pathogenic EM cells. Twist1 is not imprinted for enhanced expression in naive and CM CCR7+ Th cells. Even CCR7-CCR5+ Th1 EM cells will only express a low level of twist1 upon restimulation compared with Th cells from chronically inflamed tissue. Initial clinical studies aiming at a complete depletion of CD4+ T lymphocytes in patients with chronic inflammatory diseases suggested a clinical benefit, but the studies had to be terminated because of the severe side effects of systemic depletion of Th lymphocytes (35-37). Targeting of CD4- and CD3-expressing cells with nondepleting antibodies and neutralization of Th-related effector cytokines have demonstrated clinical efficacy (12, 13, 15, 38-40), but all of them impair protective as well as pathogenic T cell memory. Targeting of twist1-expressing Th cells, by means of either addressing twist1 or a gene regulated by it, seems more promising, because it is more specific for repeatedly restimulated Th1 memory cells involved in chronic inflammation. It remains to be shown whether these cells in chronic inflammatory diseases are the critical Th cells capable of driving inflammation, as we show in this study for the experimental model of antigen-induced arthritis.
###end p 49
###begin title 50
MATERIALS AND METHODS
###end title 50
###begin title 51
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and reagents.
###end title 51
###begin p 52
###xml 3 10 3 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lpr/lpr</sup>
###xml 3 10 3 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sup>lpr/lpr</sup></italic>
###xml 62 67 62 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1Gr</sup>
###xml 81 86 81 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tg/tg</sup>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
MRLlpr/lpr, BALB/c, C57BL/6, SCID, STAT4-deficient mice (Stat4tm1Gr), and OVA-TCRtg/tg DO11.10 mice were purchased from The Jackson Laboratory or were bred under specific pathogen-free conditions in our animal facility. T-bet-deficient mice were a gift from J. Penninger (Institute for Molecular Biotechnology of the Austria Academy of Sciences, Vienna, Austria). All animal experiments were performed in accordance with institutional, state, and federal guidelines (Landesamt Fur Gesundheit und Soziales, Berlin, Germany). Reagents were purchased from Sigma-Aldrich unless otherwise stated. BTP1 was synthesized by M. Paetzel (Humboldt University of Berlin, Berlin, Germany). Cyclosporin A was purchased from Calbiochem.
###end p 52
###begin title 53
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients.
###end title 53
###begin p 54
###xml 73 74 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 88 89 88 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib41">41</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 449 450 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 789 790 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 922 923 922 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1017 1018 1017 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1047 1048 1047 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 232 240 <span type="species:ncbi:9606">patients</span>
###xml 439 447 <span type="species:ncbi:9606">patients</span>
###xml 666 674 <span type="species:ncbi:9606">patients</span>
###xml 749 757 <span type="species:ncbi:9606">Patients</span>
###xml 880 888 <span type="species:ncbi:9606">patients</span>
###xml 982 990 <span type="species:ncbi:9606">patients</span>
###xml 1166 1174 <span type="species:ncbi:9606">patients</span>
###xml 1293 1301 <span type="species:ncbi:9606">patients</span>
Endoscopic mucosal and surgical mucosal specimens were obtained from UC (n = 9) and CD (n = 7) patients. UC and CD were diagnosed according to established clinical, endoscopic, radiological, and pathological criteria. All UC and CD patients displayed moderately to severely active disease according to the Truelove and Witts Severity Index (41) and the Harvey Bradshaw Severity Index (42), respectively. Control samples were obtained from patients (n = 4) undergoing colonectomy because of colon cancer. Mucosal control specimens used in the study were from the macroscopically noninvolved tissue distant from any detectable lesion. Synovial fluid was obtained from patients suffering from rheumatic diseases who had active synovitis with effusion. Patients with rheumatoid arthritis (RA; n = 4) fulfilled the American College of Rheumatology 1987 classification criteria for RA, patients with ankylosing spondylitis (AS; n = 5) fulfilled the modified New York criteria (1984), and patients with psoriatic arthritis (n = 3) or reactive arthritis (n = 3) fulfilled the European Spondyloarthropathy Study Group (ESSG) criteria for SpA. Clinical characteristics of the patients are listed in Table S2. All experiments were approved by the local ethics committee (Charite Ethikkommision), and all patients gave informed consent.
###end p 54
###begin title 55
###xml 13 18 <span type="species:ncbi:9606">human</span>
Isolation of human lymphocytes.
###end title 55
###begin p 56
PBMCs from buffy coats from healthy donors, and synovial fluid mononuclear cells were isolated by density gradient centrifugation (Lymphocyte separation medium; PAA). Pooled intraepithelial leukocytes and lamina propria leukocytes were obtained from mucosal specimens by treatment with collagenase type IV, followed by passage through a sieve. Mononuclear cells were collected from the 40-70% interphase of a discontinuous percoll (Pharmacia) gradient.
###end p 56
###begin title 57
Flow cytometry.
###end title 57
###begin p 58
###xml 42 48 <span type="species:ncbi:10090">murine</span>
###xml 492 497 <span type="species:ncbi:9606">human</span>
The following antibodies directed against murine antigens were either purified from hybridoma supernatants and conjugated in-house or purchased as indicated: anti-CD3 (145-2C11), anti-CD4 (GK1.5), anti-CD8 (53-6.7), anti-CD11c (N418), anti-CD44 (IM7), anti-CD62L (MEL14), anti-DO11.10 OVA-TCR (KJ1.26), anti-B220 (RA3.6B2), anti-IL2 (JES6-5H4; Caltag Laboratories), anti-IL-4 (11B11; BD Biosciences), anti-IFN-gamma (AN18.17.24), and anti-TNF-alpha (MP6-XT22; Caltag). Antibodies recognizing human antigens were obtained from BD Biosciences unless stated otherwise: anti-CD3 (OKT3; in-house conjugate), anti-CD4 (TT1; in-house conjugate), anti-CD27 (L128), anti-CD45RA (HI100), anti-CRTh2 (BM16), and anti-CCR5 (2D7/CCR5). Cells were counted by using FlowCount Beads (Beckman Coulter). Cytometric analysis was performed with FACSCalibur using CellQuest (BD Biosciences) and FCS Express (De Novo) software. Cells were separated by fluorescence-activated cell sorting (FACSAria and FACSDiva; BD Biosciences).
###end p 58
###begin title 59
Cell culture.
###end title 59
###begin p 60
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 246 253 246 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink">323-339</sub>
###xml 439 440 437 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 481 482 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 786 789 774 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 932 938 <span type="species:ncbi:10090">murine</span>
Naive CD4+CD62L+ lymphocytes from 6-8-wk-old DO11.10 mice were isolated and polarized under Th1 or Th2 conditions, as previously described (15). Irradiated (30 Gy) BALB/c splenocytes were used as APCs at a ratio of 5:1 and the cognate peptide OVA323-339 (provided by R. Volkmer-Engert, Humboldt University of Berlin, Berlin, Germany) was added at 0.5 muM. Alternatively, plates were coated with 3 mug/ml anti-CD3 (145-2C11) in PBS, and CD4+ cells were plated at a density of 2 x 106 cells/ml in medium plus 1 mug/ml soluble anti-CD28 (37.51). For Th17 differentiation, cells were stimulated in the presence of 1 ng/ml TGF-beta (R&D Systems), 20 ng/ml IL-6 (R&D Systems), and 20 ng/ml IL-23 (R&D Systems), as well as 10 mug/ml anti-IL-4 and 10 mug/ml anti-IFN-gamma. Irradiated IL-12 p35-/- splenocytes were used as APCs. Every 6 d, viable Th cells were harvested and restimulated under the original conditions, except that 10 ng/ml murine IL-2 (R&D Systems) was added to the Th1 and Th2 cultures.
###end p 60
###begin title 61
Mitogenic restimulation and intracellular cytokine staining.
###end title 61
###begin p 62
###xml 163 169 <span type="species:ncbi:10090">murine</span>
Cells were restimulated with 10 ng/ml PMA, and 1 mug/ml ionomycin or with plate-bound anti-CD3 (10 mug/ml), and soluble anti-CD28 (1 mug/ml). For restimulation of murine T cells, 10 ng/ml IL-2 was added. For intracellular staining of cytokines, T cells were stimulated for 2 h with PMA/ionomycin and an additional 3 h with 5 mug/ml of brefeldin A. Cells were fixed with 2% formaldehyde in PBS for 15 min at room temperature and permeabilized with 0.5% wt/vol saponin.
###end p 62
###begin title 63
ChIP.
###end title 63
###begin p 64
###xml 44 46 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 415 450 415 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Cp (input - immunoprecipitate)</sup>
###xml 508 514 504 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
ChIP was performed as previously described (15) using anti-NFAT1 (AB1-209; ImmunoGlobe Antikoerpertechnik), anti-p65 (C-20; Santa Cruz Biotechnology, Inc.), anti-STAT4 (C-20; Santa Cruz Biotechnology, Inc.), anti-acetyl-histone 3 (#06-599; Millipore) or anti-trimethyl-K4-histone 3 (#07-473; Millipore), followed by incubation with Protein A microbeads. The relative amount of precipitated DNA was calculated with EDeltaCp (input - immunoprecipitate). The following primers were used to amplify the proximal twist1 promoter: (-150 forward) 5'-GGGCTGGAAAGAGGAAACTT-3'; (+4 reverse) 5'-CGCGAGGTGTCTGAGAGTT-3'.
###end p 64
###begin title 65
Th1-mediated DTH model.
###end title 65
###begin p 66
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 86 87 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 211 218 211 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink">323-339</sub>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 580 582 580 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">51</sup>
###xml 631 632 625 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
The OVA-specific DTH model was performed as described elsewhere (43). In brief, 5 x 105 Th1 cells were injected i.v. into BALB/c mice, and 24 h later, the DTH response was induced by s.c. injection of 250 ng OVA323-339/IFA into the left footpad. PBS/IFA, injected into the right footpad, served as a control. The footpad thickness measured before the injection of the antigen was subtracted from the footpad thickness measured during the DTH response. The homing of adoptively transferred Th1 cells was performed as previously described (44). In brief, Th cells were labeled with 51Chromium (Amersham Buchler) at 37degreesC (2 x 107 cells/ml; 20 muCi/ml) in fresh medium. Removal of dead cells was done by gradient centrifugation (17.1% isotonic Nycodenz). Labeled cells were co-adoptively transferred into recipient animals at 1 d after the DTH induction. 24 h later, indicated tissues were removed and differential measurement of recovered radioactivity was done on a gamma counter (Wallac Counter).
###end p 66
###begin title 67
Antigen-induced arthritis.
###end title 67
###begin p 68
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
2 x 106 12-d-old GFP+ Th1 cells were transferred i.v. into naive SCID mice. 1 d later, arthritis was induced by intraarticular injection of 60 mug cationized OVA into one knee joint. The contralateral knee joint was left untreated. 21 d later, mice were killed and knee joints were fixed in 10% formaldehyde, decalcified in saturated EDTA solution, and embedded in paraffin. Knee joint sections were stained with hematoxylin/eosin and scored for exudates, granulocyte infiltration, hyperplasia, fibroblast proliferation/mononuclear cell infiltration, periarticular mononuclear cell infiltration (each scoring 0-3), bone/cartilage destruction (scoring 0-4), and an additional score of 1 for visible fibrin deposition and periarticular granulocyte infiltration, resulting in a maximum score of 21.
###end p 68
###begin title 69
Immunohistochemistry.
###end title 69
###begin p 70
###xml 245 251 <span type="species:ncbi:9793">donkey</span>
###xml 257 260 <span type="species:ncbi:10116">rat</span>
###xml 264 270 <span type="species:ncbi:9793">donkey</span>
###xml 276 280 <span type="species:ncbi:9925">goat</span>
###xml 405 409 <span type="species:ncbi:9925">goat</span>
###xml 478 482 <span type="species:ncbi:9925">goat</span>
###xml 524 530 <span type="species:ncbi:9986">rabbit</span>
###xml 595 601 <span type="species:ncbi:9986">rabbit</span>
Formalin-fixed paraffin-embedded tissue was subjected to a heat-induced epitope retrieval step and stained with anti-CD3 (#N1580; Dako), TNF-alpha (PeproTech), anti-Gr-1 (RB6-8C5; eBioscience), or F4/80 (eBioscience). For detection biotinylated donkey anti-rat or donkey anti-goat (Dianova) secondary antibodies were used followed by the streptavidin AP kit (K5005; Dako). Or sections were incubated with goat anti-TNF-alpha antibody followed by Alexa Fluor 555-conjugated anti-goat antibody (Invitrogen) and incubated with rabbit polyclonal anti-CD3 followed by Alexa Fluor 488-conjugated anti-rabbit antibody (Invitrogen). Nuclei were counterstained with DAPI (Roche), and slides were mounted in Fluoromount-G (SouthernBiotech). Images were acquired using a fluorescence microscope (AxioImager Z1) equipped with a charge-coupled device camera (AxioCam MRm) and processed with Axiovision software (Carl Zeiss, Inc.).
###end p 70
###begin title 71
Immunoblot.
###end title 71
###begin p 72
###xml 84 86 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 312 323 <span type="species:ncbi:3704">horseradish</span>
###xml 390 395 <span type="species:ncbi:10090">mouse</span>
###xml 404 410 <span type="species:ncbi:9986">rabbit</span>
Immunoblot was performed with a monoclonal Twist-specific antibody (alphaTwiMab-1) (45) conjugated in-house to digoxygenin (Roche Diagnostics), anti-tubulin-alpha (DM1A; Calbiochem), anti-T-bet (4B10; Santa Cruz Biotechnology, Inc.), or anti-IkappaBalpha (Cell Signaling Technology), followed by incubation with horseradish peroxidase-coupled anti-digoxigenin FAB-fragments (Roche) or anti-mouse or anti-rabbit (Santa Cruz Biotechnology, Inc.) secondary antibodies. Individual bands were visualized with enhanced chemiluminescence (GE Healthcare) and the Intelligent Dark Box System LAS-3000 (Fujifilm).
###end p 72
###begin title 73
Retroviral expression vectors and retroviral infection.
###end title 73
###begin p 74
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 283 289 279 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 394 395 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 799 802 795 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gfp</italic>
###xml 887 889 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 988 993 984 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t-bet</italic>
###xml 1034 1040 1030 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1325 1328 1305 1308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gfp</italic>
###xml 647 653 <span type="species:ncbi:10090">murine</span>
###xml 981 987 <span type="species:ncbi:10090">Murine</span>
###xml 1027 1033 <span type="species:ncbi:10090">murine</span>
The twist1-targeting shRNA vector was generated by amplification of the EF1alpha-promotor and GFP from pLVTHM, provided by D. Trono (Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland) followed ligation into pQCXIX (Clontech Laboratories, Inc.) with XbaI and EcoRV. The twist1 target sequence corresponds to Twist-siRNA3 (5'-AAGCTGAGCAAGATTCAGACC-3'), as published by Yang et al. (3). A corresponding scrambled sequence was used as control. The DNA oligonucleotides were subcloned using HpaI and XhoI into pLL3.7, which was provided by L. Van Parijs (Massachusetts Institute of Technology, Cambridge, MA). The fragment containing the murine U6-promotor and the shRNA-encoding sequence was amplified by PCR, introducing an additional 5'-XhoI site and ligated into the SalI site of pQXIX-gfp located in the inactivated 3'-LTR. For retroviral overexpression the vector GFP-RV (46) was used, provided by K.M. Murphy (Howard Hughes Medical Institute, St. Louis, Missouri). Murine t-bet (cDNA generated from Th1-cells), murine twist1 (IMAGE cDNA clone; AccessionID: BC033434-NCBI), and constitutively active IkappaBalphaM (pCMV-IkappaBalphaM; Clontech Laboratories, Inc.) were amplified, introducing BglII- and XhoI-compatible restriction sites and ligated into the vector upstream of the internal ribosome entry site-gfp cassette. Sequences of primers and oligonucleotides for shRNA expression are listed in Table S5. Retroviral stocks were obtained by calcium phosphate cotransfection of HEK293 cells with the retrovirus packaging plasmids pECO and pCGP. The medium was replaced after 4 h, and viral supernatants were collected 24-48 h later. Th cells were infected 40 h after activation by 60 min centrifugation at 700 g at 30degreesC with viral supernatant and 8 mug/ml polybrene, followed by replacement of the viral supernatant with the former culture supernatant.
###end p 74
###begin title 75
Luciferase reporter assay.
###end title 75
###begin p 76
###xml 171 177 <span type="species:ncbi:10090">Murine</span>
###xml 241 246 <span type="species:ncbi:10090">Mouse</span>
NF-kappaB activity was monitored using the pNF-kappaB-Luc vector (Clontech Laboratories, Inc.). Transfection efficiency was controlled by cotransfecting pRL-TK (Promega). Murine T cells were electroporated with the reporter constructs using Mouse T cell kit (AMAXA) and Nucleofector I (AMAXA). Luciferase activity was quantified with Dual Luciferase Assay kit (Promega) and a luminometer (Moonlight 3096; BD Biosciences).
###end p 76
###begin title 77
Microarray experiments.
###end title 77
###begin p 78
###xml 1243 1244 1235 1236 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1531 1532 1523 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 478 484 <span type="species:ncbi:10090">Murine</span>
Total RNA was extracted using Trizol reagent (Invitrogen), 10 mug was reverse-transcribed, followed by cDNA extraction with a PhaseLock gel (Eppendorf), and precipitated with ethanol and ammonium acetate. Biotinylated cRNA was transcribed with the MEGAscript high-yield transcription kit (Ambion), fragmented, and the hybridization cocktail was prepared according to Affymetrix protocols (15 mug fragmented biotin-labeled cRNA spiked with Eukaryotic Hybridization control). The Murine Genome U74A version 2, and 430A version 2 GeneChip arrays (Affymetrix) were hybridized at 45degreesC for 16 h, stained with streptavidin-phycoerythrin using the Affymetrix GeneChip Fluidics Workstation 400, and scanned on a Hewlett-Packard Gene Array Scanner (MGU74Av2 arrays) or on an Affymetrix GeneChip Scanner 3000 (MG430Av2 arrays). Data were analyzed using the Microarray Suite 5.0 software (Affymetrix). Microarrays were globally normalized and scaled to a trimmed mean expression value of 200. All arrays were compared with each other, and a relational database was generated using Microsoft Access software, including the following parameters: expression heights, call for presence of transcripts, P value for presence or absence of transcripts, log2 value of fold change and 95% confidence intervals, call for the significance of differentially expression, and the P value for that call. For each transcript the significance of differential expression between the groups of arrays was calculated using strict Bonferroni-corrected Welch t tests. Significantly differentially expressed genes were filtered according to the following criteria: mean fold change >/=2 or >/=1.5; difference of means >/=200; P value </=0.05; and immunoglobulin genes were excluded. Data are deposited at  (AccessionID SuperSeries: GSE11556).
###end p 78
###begin title 79
Real-time PCR.
###end title 79
###begin p 80
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 303 304 303 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink">t</sub>
###xml 304 344 304 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Cp target gene (reference - sample)</sup>
###xml 346 347 342 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink">h</sub>
###xml 347 393 343 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Cp housekeeping gene (reference - sample)</sup>
###xml 79 85 <span type="species:ncbi:10090">murine</span>
###xml 90 95 <span type="species:ncbi:9606">human</span>
Real-time PCR was performed as previously described (15). For normalization of murine and human cDNA the transcripts for the housekeeping genes hypoxanthine guanine phosphoribosyl transferase and ubiquitin ligase H5 (UbcH5) were quantified, respectively. Relative expression was calculated as follows: EtDeltaCp target gene (reference - sample)/EhDeltaCp housekeeping gene (reference - sample), where Cp represents the crossing point and E represents the reaction efficiency, determined by serial dilution of DNA. Primer sequences are listed in Table S5 (available at ).
###end p 80
###begin title 81
In silico genomic DNA analysis.
###end title 81
###begin p 82
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 46 58 46 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus</italic>
###xml 63 75 63 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homo sapiens</italic>
###xml 46 58 <span type="species:ncbi:10090">Mus musculus</span>
###xml 63 75 <span type="species:ncbi:9606">Homo sapiens</span>
The genomic sequences for the twist1 locus of Mus musculus and Homo sapiens were obtained from UCSC Genome Bioinformatics () and submitted to Matinspector analysis at .
###end p 82
###begin title 83
Statistics.
###end title 83
###begin p 84
Statistical significance in animal models (DTH and antigen-induced arthritis) was calculated using the two-tailed Mann-Whitney test (*, P < 0.05; **, P < 0.01; ***, P < 0.005).
###end p 84
###begin title 85
Online supplemental material.
###end title 85
###begin p 86
###xml 153 159 153 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 437 443 437 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 522 528 522 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 776 782 768 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1048 1054 1040 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 1294 1300 1286 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">twist1</italic>
###xml 989 995 <span type="species:ncbi:10090">murine</span>
###xml 1204 1212 <span type="species:ncbi:9606">patients</span>
###xml 1403 1409 <span type="species:ncbi:10090">murine</span>
Fig. S1 shows representative cytokine profiles of ex vivo-polarized Th1, Th2, and Th17 cells. Fig. S2 displays the result of ectopic T-bet expression on twist1 mRNA induction, as well as an immunoblot to confirm T-bet overexpression. Fig. S3 shows cytokine data and mRNA profiles of cells cultured in the simultaneous presence of IL-12 and IL-4 compared with Th1 cells. The ChIP for acetylated and trimethylated histone 3 binding to the twist1 promoter are shown in Fig. S4. The dot plots comparing cytokine expression in twist1 overexpressing and control Th cells are shown in Fig. S5. Immunoblots confirming comparable protein expression levels of Twist1 and IkappaB-alphaM upon retroviral overexpression are shown in Fig. S6. Fig. S7 displays in vivo migration capacity of twist1 overexpressing and control Th1 cells to remaining organs despite footpad and draining lymph nodes in the DTH response. Fig. S8 shows additional immunohistochemical stainings of the inflammatory response in murine arthritis. In Fig. S9, the effect of type I IFNs on twist1 induction is shown. Genes differentially expressed in once- versus four-time-stimulated Th1 cells are shown in Table S1. Clinical characteristics of patients in the study are listed in Table S2. Genes differentially expressed upon ectopic twist1 overexpression are listed in Table S3. Table S4 shows detailed results of the histological scoring in murine arthritis. Table S5 shows primer sequences. The online version of this article is available at .
###end p 86
###begin title 87
Supplementary Material
###end title 87
###begin title 88
[Supplemental Material Index]
###end title 88
###begin p 89
We thank Simone Spieckermann for excellent technical assistance in immunohistochemistry experiments. We thank R. Brothwick and C. Raulfs for critical reading; S. Pade for collection of clinical samples; D. Trono for provision of the pLVTHM vector; L. Van Parijs for pLL3.7; and K.M. Murphy for GFP-RV.
###end p 89
###begin p 90
This work was supported by the German Ministry of Education and Research (BMBF grant 1KW9913 and 0313068), within the National Genome Research Network (NGFN 1-2, BMBF grant 01GS0110, 01GS0160, 01GS0413), by the German Science Foundation (SFB 421, SFB 633) and by the European Community Grant MUGEN LSHG-CT-2005-005203. U. Niesner was a recipient of a doctoral fellowship from Boehringer Ingelheim Fonds.
###end p 90
###begin p 91
The authors have no conflicting financial interests.
###end p 91

